News

Keep up to date with us.

Visit VelacurTM at NASH-TAG 2021

Discover how fast, accurate and easy VelacurTM is to assess liver health at the NASH-TAG Conference, March 11-13, 2021. Read our poster and visit our in-person booth for live demos of Velacur, the first handheld 3D liver health assessment solution.

Developed by Sonic Incytes Medical Corp., VelacurTM is a breakthrough, point of care ultrasound solution that is redefining the standard of care for chronic liver disease. With diagnostic accuracy comparable to MRI, VelacurTM combines the principles of MRI with handheld ultrasound to quantify liver disease with greater accuracy and reliability than the current standard of care.

Interested in a private demo? Send us your request.

Follow us on LinkedInTwitter, and YouTube, and subscribe to our e-newsletter below.